ClinicalTrials.govpublic full text
OTL-200 in Patients With Late Juvenile Metachromatic Leukodystrophy (MLD)
lysosomal storage diseases, metachromatic leukodystrophy, otl-200, cryopreserved formulation, gene therapy, mld, late juvenile, atidarsagene autotemcel, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 994136
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.